Chemistry: molecular biology and microbiology – Micro-organism – per se ; compositions thereof; proces of... – Bacteria or actinomycetales; media therefor
Patent
1989-06-05
1996-04-02
Stone, Jacqueline
Chemistry: molecular biology and microbiology
Micro-organism, per se ; compositions thereof; proces of...
Bacteria or actinomycetales; media therefor
435 691, 435 693, 435 6951, 435 6952, 4351721, 4351723, 435183, 435189, 435207, 43525233, 4353201, C12N 1564, C12N 1566, C12N 1574
Patent
active
055040055
ABSTRACT:
Recombinant mycobacterial vaccine vehicles capable of expressing DNA of interest which encodes at least one protein antigen for at least one pathogen against which an immune response is desired and which can be incorporated into the mycobacteria or stably integrated into the mycobacterial genome. The vaccine vehicles are useful for administration to mammalian hosts for purposes of immunization. A recombinant vector which replicates in E. coli but not in mycobacteria is also disclosed. The recombinant vector includes 1) a mycobacterial gene or portions thereof, necessary for recombination with homologous sequences in the genome of mycobacteria transformed with the recombinant plasmid; 2) all or a portion of a gene which encodes a polypeptide or protein whose expression is desired in mycobacteria transformed with the recombinant plasmid; 3) DNA sequences necessary for replication and selection in E. coli; and 4) DNA sequences necessary for selection in mycobacteria (e.g., drug resistance). The present invention also relates to two types of recombinant vectors useful in introducing DNA of interest into mycobacteria, where it is expressed. One type of vector is a recombinant phasmid capable of replicating as a plasmid in E. coli and of lysogenizing a mycobacterial host. The other type of vector is a recombinant plasmid which can be introduced into mycobacteria, where it is stably maintained extrachromosomally.
REFERENCES:
Suarez, J. E., and Chater, K. F., Nature, 286:527-529 (1980).
Post, L. E. and Roizman, B., Cell, 25:227-232 (1981).
Crawford, J. T., et al., Review of Infec. Diseases, 3(5): 949-952 (1981).
Lotte, A., et al., Advances in Tuberculosis Research, 21:107-193 (1984).
Mackett, M., et al., J. of Virol., 49(3):857-864 (1984).
Clements, J. D. and El-Morshidy, S., Infection and Immunity, 46(2):564-569 (1984).
Labidi, A., et al., Current Microbiology, 11:235-240 (1984).
Crawford, J. T. and Bates, J. H., Gene, 27:331-332 (1984).
Labidi, A., et al., FEMS Microbiology Ltrs, 30:221-225 (1985).
Labidi, A., et al., Ann. Inst. Pasteur/Microbiol., 136B:209-215 (1985).
Crawford, J. T. and Bates, J. H., Am. Rev. Respir. Dis., 134:659-661 (1986).
Jacobs, W. R., et al., Nature, 327:532-535 (1987).
Jacobs, W. R., et al., Infection and Immunity, 52(1):101-109 (1986).
Young, R. A., et al., Proc. Natl. Acad. Sci. USA, 82:2583-2587 (1985).
Timme, T. L. and Brennan, P. J., J. of Gen. Microbiology, 130:2059-2066 (1984).
Maniats et al. (1982) Molecular Cloning p. 45.
Norgard et al, J. of Bacteriol., vol. 133, No. 3, 1254-1262 (1978).
Ramakrishnan et al. Arch. Microbiol. 120, 301-302 (1979).
Bloom Barry R.
Davis Ronald W.
Husson Robert N.
Jacobs, Jr. William R.
Young Richard A.
Albert Einstein College of Medicine of Yeshiva University
LeGuyader J.
Stone Jacqueline
The Board of Trustees of the Leland Stanford Jr. University
Whitehead Institute for Biomedical Research
LandOfFree
Recombinant mycobacterial vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant mycobacterial vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant mycobacterial vaccine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2015865